Short Interest in Ibere Pharmaceuticals (NYSE:IBER) Declines By 73.2%

Ibere Pharmaceuticals (NYSE:IBER) was the target of a large decrease in short interest during the month of August. As of August 31st, there was short interest totalling 2,200 shares, a decrease of 73.2% from the August 15th total of 8,200 shares. Based on an average daily volume of 4,500 shares, the short-interest ratio is presently 0.5 days.

NYSE:IBER traded up $0.02 on Wednesday, hitting $9.66. The company had a trading volume of 76,062 shares, compared to its average volume of 10,759. The company’s 50 day moving average price is $9.67. Ibere Pharmaceuticals has a 52 week low of $9.60 and a 52 week high of $9.95.

About Ibere Pharmaceuticals

Ibere Pharmaceuticals focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in Philadelphia, Pennsylvania.

Further Reading: How does the Federal Reserve determine interest rates?

Receive News & Ratings for Ibere Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ibere Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.